Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations

Clinical Lymphoma, Myeloma and Leukemia

Volumn 12, Issue 1, 2012, Pages 20-25

  Mehta, Neha ^a   Wayne, Alan S ^b   Kim, Youn H ^c   Hale, Gregory A ^d   Alvarado, Carlos S ^e   Myskowski, Patricia ^f   Jaffe, Elaine S ^b   Busam, Klaus J ^f   Pulitzer, Melissa ^f   Zwerner, Jeffrey ^c   Horwitz, Steven ^f  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bexarotene; Cutaneous gamma delta T cell lymphoma; Subcutaneous panniculitis like T cell lymphoma

Indexed keywords

BEXAROTENE; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CUTANEOUS T CELL LYMPHOMA; DATA BASE; DRUG RESPONSE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MAINTENANCE THERAPY; MALE; PANNICULITIS; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICARCINOGENIC AGENTS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANNICULITIS; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863115840     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.06.016     Document Type: Article

References (30)

1. C.l. Gonzalez, L.J. Medeiros, R.M. Braziiel T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome Am J Surg Pathol 15 1991 17 27
2. E.S. Jaffe, N.L. Harris, H. Stein World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Hematopoetic and Lymphoid Tissues 2001 IARC Press Lyon, France
3. E.S. Jaffe, N.L. Harris, H. Stein Classification of lymphoid neoplasms: the microscope as a tool for disease discovery Blood 112 2008 4384 4399
4. R. Willemze, E.S. Jaffe, G. Burg WHO-EORTC classification for cuteanous lymphomas Blood 105 2005 3768 3785
5. F. Gallardo, R.M. Pujol Subcutaneous panniculitic-like T-cell lymphoma and other primary cutaneous lymphomas with prominent subcutaneous tissue involvement Dermatol Clin 26 2008 529 540
6. D.D. Weisenburger, K.J. Savage, N.L. Harris Peripheral T-celly lymphoma, not otherwise specificed: a report of 340 cases from the International T-cell Lymphoma Project Blood 117 2011 3402 3408
7. M.J. Koh, S.P. Sadarangani, Y.C. Chan Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children J Am Acad Dermatol 61 2009 875 881
8. R. Willemze, P.M. Jansen, L. Cerroni Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: and EORTC Cutaneous Lymphoma Group Study of 83 cases Blood 111 2008 838 845
9. T.B. Cassis, P.K. Fearneyhough, J.P. Callen Subcutaneous panniculitis-like T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematous panniculitis J Am Acad Dermatol 50 2004 465 469 (Pubitemid 38316146)
10. M. Santucci, N. Pimmpinelli, D. Massi Cytotoxic/natural killer cell cutaneous lymphomas Report of EORTC Cutaneous Lymphoma Task Force Workshop Cancer 97 2003 610 627 (Pubitemid 36125838)
11. K.E. Sahany, W.R. Macon, J.K. Choi Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic and genotypic analysis of alpha/beta and gamma/delta subtypes Am J Surg Pathol 22 1998 881 893 (Pubitemid 28328234)
12. I. Ghobrial, R. Weenig, M.R. Pittlekow Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma Leuk Lymphoma 46 2005 703 708 (Pubitemid 40775218)
13. K.J. Savage, M. Chhanabhai, R.D. Gascoyne Characterizatin of peripheral T-cell lymphomas in a single North American institution by the WHO classification Ann Oncol 15 2004 1467 1475 (Pubitemid 39409735)
14. J.R. Toro, D.J. Liewehr, N. Pabby Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma Blood 101 2003 3407 3412 (Pubitemid 36857921)
15. M. Takeshita, S. Imayama, Y. Oshiro Clinicopathologic analysis of 22 cases of subcutaneous panniculitis-like CD56- or CD56+ lymphoma and review of 44 other reported cases Am J Clin Pathol 121 2004 408 416 (Pubitemid 38298175)
16. Z. Parveen, K. Thompson Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnositic criteria in the recent World Health Organization-European Organization for research and treatment of cancer classification for cutaneous lymphomas Arch Pathol Lab Med 133 2009 303 308
17. M. Guizzardi, I.A. Hendrickx, L.L. Mancini Cytotoxic gamma/delta subcutaneous panniculitis-like T-cell lymphoma: report of a case with pulmonary involvement unresponsive to therapy J Eur Acad Dermatol Venereol 17 2003 219 222 (Pubitemid 36416795)
18. R.S. Go, S.M. Wester Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma A systematic analysis of 156 patients reported in the literature Cancer 101 2004 1404 1413 (Pubitemid 39180396)
19. T. Hathaway, A. Subtil, P. Kuo Efficacy of denileukin diftitox in subcutaneous pannicultitis-like T-cell lymphoma Lymphoma Myeloma 7 2007 541 545 (Pubitemid 350043493)
20. N.L. Harris, W.F. McNeely, J. Shepard Case 34-2001 a 54-year-old woman with multiple sclerosis, prolonged fever, and skin Nodules N Engl J Med 345 2001 1409 1415
21. K.S. McGinnis, M. Shapiro, J.M. Junkins-Hopkins Denileukin diftitox for the treatment of panniculitic lymphoma Arch Dermatol 138 2002 740 742 (Pubitemid 34625516)
22. R.A. Abbott, S.J. Whittaker, S.L. Morris Bexarotene therapy for mycosis fungoides and Sezary syndrome Br J Dermatol 160 2009 1299 1307
23. M. Duvic, K. Hymes, P. Heald Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results J Clin Oncol 19 2001 2456 2471 (Pubitemid 32391217)
24. R.A. Krathen, S. Ward, M. Duvic Bexarotene is a new treatment option for lymphomatoid papulosis Dermatology 206 2003 142 147 (Pubitemid 36205282)
25. L. Qu, X. Tang Bexarotene: a promising anticancer agent Cancer Chemother Pharmacol 65 2010 201 205
26. C. Zhang, P. Hazarika, X. Ni Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action Clin Cancer Res 8 2002 1234 1240 (Pubitemid 34517663)
27. M. Ichii, K. Hatanaka, M. Imakita Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood bone marrow transplantation from HLA-mismatched sibling donor Leuk Lymph 47 2006 2250 2252 (Pubitemid 44650106)
28. R. Talpur, S. Ward, N. Apisarnthanarax Optimizing bexarotene therapy for cutaneous T-cell lymphoma J Am Acad Derm 47 2002 672 684 (Pubitemid 35239327)
29. A. Molina, R. Advani, S. Reddy Bexarotene is highly active in the treatment of subcutaneous panniculitis-like T-cell lymphoma Blood 106 2005 3344 (abstract)
30. S.I. Sherman, J. Gopal, B.R. Haugen Central hypothyroidism associated with retinoid X receptor-selective ligands N Engl J Med 340 1999 1075 1079 (Pubitemid 29162512)